Compound Detail
CHEMBL4100261
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4100261 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SPQXTNMVIOBROQ-LCLDVOFVSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
363.4
MW (Da)
2.60
ALogP
6
HBA
2
HBD
84.5
PSA (Ų)
0.50
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 4.21 | 4.21 | 61000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 61000.0 | nM | 4.21 | Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after ... | 28743492 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28743492 | 10.1016/j.bmc.2017.07.009 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine